Aspirin Use among Adults with Cardiovascular Disease in the United States: Implications for an Intervention Approach

Journal of Clinical Medicine
Benjamin E AnsaTara Johnson

Abstract

Cardiovascular disease (CVD) is a major underlying cause of death, with high economic burden in most countries, including the United States. Lifestyle modifications and the use of antiplatelet therapy, such as aspirin, can contribute significantly to secondary prevention of CVD in adults. This study examined the prevalence and associated factors of aspirin use for the secondary prevention of angina pectoris, myocardial infarction (MI), and cerebrovascular disease (stroke) in a sample of American adults. The 2015 Behavioral Risk Factor Surveillance System (BRFSS) dataset was analyzed for this cross-sectional study. Almost 16% of the study population (N = 441,456) had angina, MI, or stroke. Weighted percentages of respondents with angina, MI, and stroke were 4%, 4.3%, and 3%, respectively. Overall, weighted prevalence of daily (or every other day) aspirin use was about 65%, 71%, and 57% among respondents with angina, MI, and stroke, respectively. Factors that were significantly associated with aspirin use included male sex, more than high school education, high blood pressure, diabetes, and less than excellent general health. There were existing differences among individuals with CVD based on diagnosis, demographic and socioecono...Continue Reading

References

Nov 1, 2003·Thrombosis Research·J R Vane, R M Botting
Jun 9, 2005·Annals of Internal Medicine·Cynthia Mulrow, Michael Pignone
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Jan 19, 2006·JAMA : the Journal of the American Medical Association·Jeffrey S BergerDavid L Brown
Mar 14, 2007·Journal of General Internal Medicine·Alexander R OpotowskyChristopher P Cannon
Sep 21, 2007·Atherosclerosis·Ian GrahamUNKNOWN ESC Committee for Practice Guidelines
Feb 16, 2011·British Journal of Clinical Pharmacology·Timothy D WarnerCarl Whatling
Apr 5, 2011·The Canadian Journal of Cardiology·Alan D BellJean-François Tanguay
Feb 28, 2014·Clinical Medicine & Research·Sunitha V IttamanShereif H Rezkalla
Dec 25, 2015·Journal of the American Heart Association·Russell V LuepkerAlan T Hirsch
Aug 23, 2016·Texas Heart Institute Journal·Robert W Godley, Eduardo Hernandez-Vila
Nov 16, 2016·International Journal of Environmental Research and Public Health·Benjamin E AnsaSelina A Smith
Mar 14, 2017·JRSM Cardiovascular Disease·Jack StewartPeter Wilkinson
Sep 8, 2017·Preventing Chronic Disease·Vincent L MendyLei Zhang
Aug 31, 2018·Lancet·Davide Capodanno, Dominick J Angiolillo

❮ Previous
Next ❯

Citations

Jun 24, 2020·Postgraduate Medicine·Morgan Spencer GoldMoshe Ben-Shoshan
Apr 2, 2021·Journal of Theoretical Biology·Muhammad Suleman AwanAfrose Liaquat
Jun 1, 2021·Human Genetics·Luis M García-MarínMiguel E Rentería
Feb 23, 2020·Journal of Voice : Official Journal of the Voice Foundation·Daniel EichornRobert T Sataloff
Oct 28, 2021·Stroke; a Journal of Cerebral Circulation·Jay B LuskYing Xian

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.